Blood test for early ovarian cancer detection in BRCA carriers
Part of Cancer, Genetic & congenital, Hormones & metabolism, Skin, Women’s health & pregnancy clinical trials.
This study is testing a blood test that may help find ovarian cancer earlier in people with BRCA1 or BRCA2 gene changes. It involves giving blood samples before and after surgery to remove the ovaries and fallopian tubes, or over several years if you've had a precancerous lesion found.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 35 years or older.
- You have a confirmed BRCA1 or BRCA2 gene change (mutation) that increases cancer risk.
- You are planning to have surgery to remove your ovaries and/or fallopian tubes to reduce cancer risk, or you've had a precancerous lesion (STIC) found in the past 10 years.
- You can understand and sign a consent form in English.
- You are not pregnant or breastfeeding, and you do not have an active cancer diagnosis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a new blood test that looks for DNA changes to help detect ovarian cancer earlier. You would give a blood sample before your planned surgery or biopsy, and researchers will compare the test results with your pathology report to see how accurate it is.
This study checks whether a sample of fluid from the uterus (uterine lavage) can help detect ovarian or fallopian tube cancer. You may join if you are having certain gynecologic surgeries or, in a smaller group, you have a BRCA1/2 mutation.
This study looks at tiny molecules in your blood (called microRNAs) to see if they can help doctors identify and manage malignant ovarian germ cell tumors. By giving a blood sample at diagnosis, you may help improve future detection and treatment for this rare cancer.
This trial studies whether a simple blood test (liquid biopsy) can help tell if an ovarian mass is cancer or not, and if it can catch cancer early. If you're going to have surgery for a suspicious ovarian mass, this test might give extra information to guide your care.
This study is testing a new blood test to help find ovarian cancer early in women who are at average risk. By joining, you may help improve early detection, which could lead to better outcomes.
This study is testing a blood test to see if it can catch ovarian cancer early. You may be eligible if you have been recently diagnosed with ovarian cancer and haven't started treatment yet.
Hear when a new Ovarian Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.